What's Happening?
The global market for rare disease genetic testing is expected to grow significantly, reaching $5.72 billion by 2035, according to a study by SNS Insider. This growth is driven by advancements in sequencing technology, expanded newborn screening programs,
and the use of artificial intelligence in genomic interpretation. The market, valued at $1.40 billion in 2025, is projected to grow at a compound annual growth rate (CAGR) of 15.36% from 2026 to 2035. The report highlights the importance of reducing the time needed to diagnose rare genetic diseases, which can lead to earlier treatment. Molecular Genetic Tests were the largest segment in 2025, while Biochemical Genetic Tests are expected to grow steadily. The U.S. market, a significant contributor, is projected to grow from $0.42 billion in 2025 to $1.80 billion by 2035.
Why It's Important?
The expansion of the rare disease genetic testing market is crucial for improving diagnostic accuracy and treatment options for patients with rare genetic conditions. The integration of genomic testing into clinical practice enhances the ability of healthcare providers to diagnose and treat these conditions more effectively. This growth also reflects increased investment in genomics by governments, healthcare organizations, and biotech firms, which is essential for advancing precision medicine. The U.S. market's growth underscores the country's leadership in genomic infrastructure and research funding, which could lead to better health outcomes for patients with rare diseases.
What's Next?
The market is expected to continue evolving with technological advancements in sequencing and bioinformatics. The focus will likely remain on improving diagnostic capabilities and expanding access to genetic testing. As the market grows, collaborations between research facilities and diagnostic centers are expected to increase, further integrating genomic testing into healthcare systems. The U.S. market will continue to play a pivotal role, with ongoing investments in genomic technologies and personalized healthcare solutions.
